IRIX

IRIDEX Corp

0.7214

Nov 02 • 3:59 PM ET +0.0095 (1.34%)

0.7242

Aftermarket • 7:44 PM ET +0.0028 (0.38%)

Healthcare Medical Devices USA Nano NASD

Peers: LNSR GKOS SGHT RXST SRTS ALC APYX BLCO STAA HROW

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	12.67M
Enterprise Value	18.00M
Income	-3.55M
Sales	51.57M
Book/sh	-0.14
Cash/sh	0.27
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	93
IPO	Feb 16, 1996

P/E	-
Forward P/E	-
PEG	-
P/S	0.25
P/B	-
P/C	2.71
P/FCF	-
EV/EBITDA	-
EV/Sales	0.35
Quick Ratio	1.08
Current Ratio	1.82
Debt/Eq	1.10
LT Debt/Eq	1.06
Option/Short	Yes / Yes

EPS (ttm)	-0.21
EPS next Y	0.00
EPS next Q	-0.04
EPS this Y	53.85%
EPS next Y	100.00%
EPS next 5Y	-
EPS past 3/5Y	17.90% 10.54%
Sales past 3/5Y	-2.58% 7.70%
EPS Y/Y TTM	36.91%
Sales Y/Y TTM	3.68%
EPS Q/Q	-22.80%
Sales Q/Q	-7.41%
Earnings	Aug 18 AMC
EPS/Sales Surpr.	-600.00% -7.51%

Insider Own	38.84%
Insider Trans	21.87%
Inst Own	17.53%
Inst Trans	-0.40%
ROA	-12.06%
ROE	-73.15%
ROIC	-47.22%
Gross Margin	35.31%
Oper. Margin	-5.39%
Profit Margin	-6.88%
SMA20	-8.59%
SMA50	0.58%
SMA200	-30.37%
Trades

Shs Outstand	17.45M
Shs Float	10.74M
Short Float	0.71%
Short Ratio	0.20
Short Interest	0.08M
52W High	1.65 -56.23%
52W Low	0.61 18.86%
Volatility	5.84% 11.82%
ATR (14)	0.06
RSI (14)	44.66
Beta	0.65
Rel Volume	0.05
Avg Volume	388.39K
Volume	19,121

Perf Week	-4.32%
Perf Month	12.17%
Perf Quarter	-12.04%
Perf Half Y	-33.51%
Perf YTD	-36.71%
Perf Year	-31.29%
Perf 3Y	-67.36%
Perf 5Y	-91.14%
Perf 10Y	-94.49%
Recom	1.00
Target Price	2.75
Prev Close	0.71
Price	0.72
Change %	1.34%

Consensus

Strong Buy

Avg. Price Target

$2.75

Implied Upside

+281.2%

Analysts3incl. previous ratings

Rating Distribution3 Buy · 0 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Nov 03, 2017	Resumed	RROTH Capital	Buy
Dec 21, 2016	Initiated	RROTH Capital	Buy
Jan 26, 2016	Initiated	SSingular Research	Buy	$11.50	+1,494.0%
Jan 03, 2007	Initiated	FFirst Albany	Buy	$15.50	+2,048.5%

Oct-12-26 07:00AM	Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse Technology for Early to Advanced Glaucoma (GlobeNewswire)
Oct-05-26 07:00AM	Iridex Completes Relocation of Manufacturing Facility to San Jose, California (GlobeNewswire) +7.28%
Aug-19-26 01:00AM	IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ... (GuruFocus.com) -15.83%
Aug-18-26 04:15PM	Iridex: Q2 Earnings Snapshot (Associated Press) +5.69%
04:05PM	Iridex Reports Second Quarter 2026 Financial Results (GlobeNewswire)
04:05PM	Loading…
Aug-04-26 04:05PM	Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 (GlobeNewswire)
Jul-20-26 07:00AM	Iridex Adds EndoProbe Handpieces to EyeProGPO Product Offering (GlobeNewswire)
Jun-09-26 04:05PM	Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference (GlobeNewswire)
May-20-26 01:00AM	IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-19-26 04:11PM	Iridex: Q1 Earnings Snapshot (Associated Press)
04:05PM	Iridex Reports First Quarter 2026 Financial Results (GlobeNewswire)
May-05-26 04:05PM	Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 (GlobeNewswire)
Apr-07-26 04:05PM	Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology (GlobeNewswire)
Mar-26-26 04:37PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance) -26.67%
04:05PM	Iridex Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
04:05PM	Loading…
Mar-12-26 04:05PM	Iridex to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026 (GlobeNewswire)
Feb-02-26 07:00AM	Iridex Announces Plans to Relocate Headquarters (GlobeNewswire)
Jan-12-26 07:00AM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 (GlobeNewswire) +28.70%
Jan-02-26 09:35AM	Zacks Initiates Coverage of Iridex With Neutral Recommendation (Zacks)
Dec-11-25 07:00AM	Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse Technology in Glaucoma Management (GlobeNewswire)
Dec-08-25 07:00AM	Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse Technology and Continuous-Wave Laser for Glaucoma Treatment (GlobeNewswire)
Dec-05-25 07:00AM	Iridex to Present at the Sidoti Year-End Virtual Investor Conference (GlobeNewswire)
Nov-12-25 12:00AM	IRIDEX Corp (IRIX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Cost Management (GuruFocus.com) -19.82%
Nov-11-25 04:08PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance) +8.18%
04:05PM	Iridex Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:05PM	Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 (GlobeNewswire)
Sep-09-25 04:05PM	Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance (GlobeNewswire)
Aug-13-25 03:13AM	IRIDEX Corp (IRIX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost Challenges (GuruFocus.com) -9.23%
Aug-12-25 04:28PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2025 Financial Results (GlobeNewswire)
04:05PM	Loading…
Jul-29-25 04:05PM	Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire) -8.50%
Jun-30-25 06:45AM	Vicarious Surgical Announces Election of New Directors (Business Wire)
Jun-24-25 07:00AM	Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema (GlobeNewswire)
May-14-25 03:17AM	IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... (GuruFocus.com) -9.09%
May-13-25 04:33PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 06:00PM	IRIDEX Changes Course (Seeking Alpha)
Apr-30-25 04:05PM	Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-16-25 07:11PM	IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) (Seeking Alpha)
Apr-14-25 04:05PM	Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 (GlobeNewswire) +5.04%
Apr-09-25 04:05PM	Iridex to Host Strategic Vision Call on April 16, 2025 (GlobeNewswire) +10.67%
Mar-28-25 08:48AM	Q4 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) +13.15%
03:04AM	IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... (GuruFocus.com)
Mar-27-25 06:03PM	IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:36PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-19-25 09:15AM	Iridex Announces Strategic Investment in the Company (GlobeNewswire) -20.79%
Mar-14-25 07:00AM	Iridex Comments on Recent Stock Price Volatility (GlobeNewswire) +16.49%
Mar-13-25 05:00PM	Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 (GlobeNewswire) -21.14%
Jan-14-25 07:24AM	Iridex: Q4 Sales To Match Performance Of Prior Year (RTT News)
07:00AM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Dec-18-24 04:05PM	Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management (GlobeNewswire)
Nov-19-24 08:14AM	Iridex Comments on Changing Glaucoma Reimbursement Landscape (GlobeNewswire)
Nov-13-24 02:20AM	IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... (GuruFocus.com) +34.04%
Nov-12-24 04:40PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-04-24 04:05PM	Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire) -5.02%
Oct-09-24 05:59PM	IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -6.96%
Oct-03-24 04:05PM	Iridex Appoints Patrick Mercer as Chief Executive Officer (GlobeNewswire)
Aug-08-24 09:57PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:15PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:13PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 08:00AM	Iridex Announces Convertible Note Financing (GlobeNewswire) -9.74%
Jul-30-24 04:05PM	Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
May-15-24 07:46AM	Q1 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -13.96%
03:12AM	IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-14-24 06:00PM	Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:55PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-08-24 04:05PM	Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Mar-27-24 10:39AM	IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript (Insider Monkey) +17.53%
10:10AM	Q4 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 08:53PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:05PM	Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
05:06PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-20-24 04:05PM	Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024 (GlobeNewswire)
Feb-06-24 08:00AM	Iridex Corporation Receives European Patent on MicroPulse Technology (GlobeNewswire)
Jan-24-24 08:00AM	Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust (GlobeNewswire)
Jan-11-24 06:45PM	Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma (GlobeNewswire)
Dec-28-23 06:00PM	Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation (GlobeNewswire)
Nov-27-23 09:00AM	Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation (GlobeNewswire) +19.00%
Nov-14-23 05:06PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance) -7.32% +6.84%
04:21PM	Iridex Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-13-23 09:00AM	Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023 (GlobeNewswire)
Oct-26-23 04:22PM	Iridex to Report Third Quarter Financial Results on November 14, 2023 (GlobeNewswire)
Aug-29-23 04:05PM	Iridex Announces Strategic Review to Unlock Shareholder Value (GlobeNewswire) +6.57% +13.70%
Aug-11-23 06:59AM	Q2 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -28.25%
Aug-10-23 06:30PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:23PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 08:46AM	We Think IRIDEX (NASDAQ:IRIX) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jul-27-23 04:05PM	Iridex to Report Second Quarter Financial Results on August 10, 2023 (GlobeNewswire)
Jun-21-23 05:00AM	Zacks Industry Outlook Highlights IPG Photonics and IRIDEX (Zacks)
Jun-20-23 12:25PM	2 Laser Systems Stocks to Buy in a Prospering Industry (Zacks)
Jun-08-23 07:06AM	IRIDEX Corporation's (NASDAQ:IRIX) Price Is Right But Growth Is Lacking (Simply Wall St.)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lin Shih-Yao David	10% Owner	Feb 05 '26	Buy	1.45	40,535	58,755	1,098,858	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Jan 27 '26	Buy	1.48	33,013	49,014	1,034,312	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Jan 23 '26	Buy	1.48	30,000	44,394	1,001,299	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 17 '26	Buy	1.31	22,805	29,872	1,157,363	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 04 '26	Buy	1.41	19,324	27,247	1,058,323	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Jan 08 '26	Buy	1.20	20,000	24,000	971,299	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 23 '26	Buy	1.33	17,526	23,310	1,174,889	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 11 '26	Buy	1.43	15,703	22,455	1,114,690	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 23 '26	Buy	1.41	14,943	21,070	1,129,733	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 12 '25	Buy	0.97	20,000	19,400	905,648	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 09 '25	Buy	0.94	20,000	18,800	866,756	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 10 '25	Buy	0.94	18,892	17,664	885,648	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 19 '25	Buy	0.97	14,202	13,776	938,929	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 15 '25	Buy	0.94	11,404	10,720	917,052	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 05 '25	Buy	0.94	10,260	9,644	846,756	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 30 '25	Buy	1.15	7,009	8,060	949,969	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 16 '25	Buy	0.99	7,675	7,598	924,727	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 30 '26	Buy	0.99	7,371	7,297	1,186,809	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 24 '26	Buy	1.33	4,549	6,050	1,179,438	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Jan 30 '26	Buy	1.48	4,050	5,994	1,038,362	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 22 '25	Buy	1.00	4,031	4,031	942,960	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 16 '26	Buy	1.30	1,682	2,187	1,134,558	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 02 '26	Buy	1.40	1,424	1,994	1,131,157	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Jan 07 '26	Buy	1.19	1,330	1,583	951,299	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 12 '26	Buy	1.32	967	1,276	1,132,876	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Mar 03 '26	Buy	1.42	752	1,068	1,131,909	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 02 '26	Buy	1.49	637	949	1,038,999	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Dec 03 '25	Buy	0.93	244	227	836,496	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 09 '26	Buy	1.46	129	188	1,098,987	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Feb 12 '26	Buy	1.38	100	138	1,114,790	Oct 07 06:10 AM
Lin Shih-Yao David	10% Owner	Nov 14 '25	Buy	0.88	24,626	21,624	808,340	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 12 '25	Buy	1.04	20,000	20,800	783,714	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Dec 01 '25	Buy	0.96	20,000	19,200	836,252	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 28 '25	Buy	0.96	3,885	3,730	816,252	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 26 '25	Buy	0.93	3,033	2,821	812,367	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 06 '25	Buy	1.04	1,496	1,556	763,599	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 20 '25	Buy	0.94	925	870	809,265	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 07 '25	Buy	1.04	115	120	763,714	Oct 07 06:08 AM
Lin Shih-Yao David	10% Owner	Nov 25 '25	Buy	0.91	69	63	809,334	Oct 07 06:08 AM
Dizon Romeo R	Chief Financial Officer	Sep 16 '26	Buy	0.63	7,900	4,977	185,306	Sep 16 04:26 PM
Dizon Romeo R	Chief Financial Officer	Sep 14 '26	Buy	0.65	2,354	1,530	177,406	Sep 14 11:39 AM
Dizon Romeo R	Chief Financial Officer	Sep 10 '26	Buy	0.68	5,100	3,468	175,052	Sep 10 11:53 AM
Dizon Romeo R	Chief Financial Officer	Aug 24 '26	Buy	0.75	6,668	4,999	169,952	Aug 24 12:03 PM
Dizon Romeo R	Chief Financial Officer	Jun 12 '26	Buy	1.14	975	1,110	135,975	Jun 15 11:40 AM
Dizon Romeo R	Chief Financial Officer	Jun 11 '26	Buy	1.14	1,675	1,909	135,000	Jun 12 02:45 PM
Dizon Romeo R	Chief Financial Officer	Jun 08 '26	Buy	1.12	2,400	2,688	133,325	Jun 09 09:23 AM
Dizon Romeo R	Chief Financial Officer	Jun 05 '26	Buy	1.15	2,521	2,899	130,925	Jun 08 09:54 AM
Dizon Romeo R	Chief Financial Officer	Jun 03 '26	Buy	1.17	2,400	2,808	128,404	Jun 03 01:33 PM
Dizon Romeo R	Chief Financial Officer	May 26 '26	Buy	1.00	5,004	5,004	126,004	May 26 11:40 AM
Dizon Romeo R	Chief Financial Officer	Mar 06 '26	Buy	1.26	1,110	1,399	121,000	Mar 09 01:05 PM
Dizon Romeo R	Chief Financial Officer	Feb 17 '26	Buy	1.34	2,200	2,942	119,890	Feb 17 12:55 PM
Dizon Romeo R	Chief Financial Officer	Feb 12 '26	Buy	1.43	1,500	2,145	117,690	Feb 12 10:05 AM
Dizon Romeo R	Chief Financial Officer	Feb 10 '26	Buy	1.46	1,000	1,460	116,190	Feb 10 03:19 PM
Dizon Romeo R	Chief Financial Officer	Feb 03 '26	Buy	1.38	2,500	3,450	115,190	Feb 03 06:21 PM
Dizon Romeo R	Chief Financial Officer	Jan 29 '26	Buy	1.44	1,101	1,588	112,690	Jan 29 03:58 PM
Dizon Romeo R	Chief Financial Officer	Jan 28 '26	Buy	1.46	1,300	1,898	111,589	Jan 28 01:13 PM
Dizon Romeo R	Chief Financial Officer	Jan 27 '26	Buy	1.48	3,385	5,009	110,289	Jan 27 01:14 PM
Dizon Romeo R	Chief Financial Officer	Jan 26 '26	Buy	1.52	1,243	1,889	106,904	Jan 26 10:22 AM
Dizon Romeo R	Chief Financial Officer	Jan 23 '26	Buy	1.48	5,221	7,716	105,661	Jan 23 02:48 PM
Dizon Romeo R	Chief Financial Officer	Jan 21 '26	Buy	1.50	2,159	3,233	100,440	Jan 21 02:10 PM
Dizon Romeo R	Chief Financial Officer	Jan 20 '26	Buy	1.50	2,100	3,147	98,281	Jan 21 02:10 PM
Dizon Romeo R	Chief Financial Officer	Jan 16 '26	Buy	1.43	3,496	5,006	96,181	Jan 16 05:01 PM
MOORE WILLIAM M	Director	Dec 16 '25	Buy	1.01	2,000	2,020	251,550	Dec 18 02:55 PM
Dizon Romeo R	Chief Financial Officer	Dec 12 '25	Buy	0.97	2,365	2,296	92,685	Dec 15 11:21 AM
Dizon Romeo R	Chief Financial Officer	Dec 02 '25	Buy	0.95	1,584	1,498	90,320	Dec 04 04:02 PM
Dizon Romeo R	Chief Financial Officer	Nov 20 '25	Buy	0.96	5,760	5,530	88,736	Nov 21 10:04 AM
Dizon Romeo R	Chief Financial Officer	Nov 19 '25	Buy	0.96	1,000	960	82,976	Nov 20 11:42 AM
Dizon Romeo R	Chief Financial Officer	Nov 18 '25	Buy	0.94	2,133	2,005	81,976	Nov 19 09:05 AM
MOORE WILLIAM M	Director	Nov 14 '25	Buy	0.97	28,157	27,245	228,831	Nov 18 02:56 PM
MOORE WILLIAM M	Director	Nov 17 '25	Buy	0.97	21,843	21,087	250,674	Nov 18 02:56 PM
Dizon Romeo R	Chief Financial Officer	Nov 17 '25	Buy	0.96	3,124	2,999	79,843	Nov 18 09:58 AM
Dizon Romeo R	Chief Financial Officer	Nov 14 '25	Buy	0.88	14,769	12,997	76,719	Nov 17 09:05 AM

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Executive ChairmanMr. Scott A. Shuda J.D.

CEOMr. Patrick Mercer

Chief Financial OfficerMr. Romeo R. Dizon

SVP of International Sales & Business DevelopmentMr. Bassem BouHabib

Head of Investor RelationsMs. Leigh Salvo

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRIX

IRIDEX Corp

Upgrade your Finviz experience